Navigation Links
ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
Date:1/8/2009

ge biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to (i) the potency, safety and tolerability profile of ANA598, which may not be duplicated in future cohorts at higher doses or future clinical studies of longer duration; (ii) the belief that ANA598 is a leading non-nucleoside polymerase inhibitor in development for the treatment of HCV and the ability to use ANA598 in combination with other anti-HCV agents in the future; (iii) the potential for once-daily or twice-daily oral dosing of ANA598; (iv) the ability of Anadys to transition into Phase II studies of ANA598 during 2009; and (v) expectations regarding the evolution of the market for HCV therapies. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. For example, the results of preclinical and early clinical studies (including those described in this press release) may not be predictive of future results, and Anadys cannot provide any assurances that ANA598 will not have unforeseen safety issues, will have favorable results in future cohorts of the Phase Ib study or future clinical trials, will maintain fast track designation or will receive regulatory approval. In addition, Anadys' results may be
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
8. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
9. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Decision ... colitis (CD/UC) patients eligible for biologic therapy, ... a biologic. Surveyed gastroenterologists cite patients, discomfort ... for low penetration rates, followed by cost-related ... UC patients receiving biologics, Janssen Biotech,s Remicade ...
(Date:9/17/2014)... , Sept. 17, 2014 ACIST Medical Systems, ... leader of advanced imaging modalities for cardiology, showcased the ... two live cases at the Transcatheter Cardiovascular Therapeutics meeting ... were presented from Medstar Washington Hospital Center ( ... Medical Center ( New York, NY ). ...
(Date:9/17/2014)... , Sept. 17, 2014  Bayer HealthCare will ... Hemophilia Foundation,s 66 th Annual Meeting, which takes ... D.C.  The data, which will be shared through poster ... and patient care. Data will be presented in a ... into treatment modalities in hemophilia A patients, Bayer is ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3ACIST Launches HDi High-Definition IVUS 2ACIST Launches HDi High-Definition IVUS 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4
... Nov. 1, 2010 Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostics ... to serving the healthcare needs of women, today ... Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy ...
... Nov. 1, 2010 Inovonics ( http://www.inovonics.com ), the ... commercial and life safety applications, today announced the ... sensor solution designed specifically to meet the unique ... motion-sensing technology, the EN1240 offers a significant advancement ...
Cached Medicine Technology:Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 3Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 2Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 3Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 4
(Date:9/18/2014)... (PRWEB) September 18, 2014 With ... have special functions of adjusting human body physiology, ... won great popularity with a variety of specific ... food in China reached RMB187.4 billion, up 12.0% ... during 2006-2013. , View Full Report at ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 SpineFrontier ... team and surgeon partners in Less Exposure Surgery ... SpineFrontier, Tamara authored an extensive education curriculum and ... Masters in Science in Organizational Leadership, and has ... for eleven years. Bringing her to the team ...
(Date:9/18/2014)... Dr. Suzaunna Clark, Psychologist, Life Coach and Licensed ... to be seen to be believed and 2- that ... be used. Together, both lead to hearts that heal. ... do both. , Dr. Clark offers professional ... system, which provides professional guidance on dealing with everyday ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Specialty ... in Westlake, OH, announces that they have achieved ... PowerServer, a Complete Certified Ambulatory EHR-certified system developed ... Specialty Teleradiology had a non MU compliant PACS ... their business grew from a niche in oncology ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 N-Zyme Scientifics ... successfully launching its first product a mere 8 months ... is a high performance glycan release enzyme used in ... research, and the basis for tissue pathology on Mass ... (Portsmouth, NH) for the North American market (PNGase F ...
Breaking Medicine News(10 mins):Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 2Health News:Specialty Teleradiology Attains Meaningful Use with PowerServer MU 3Health News:N-Zyme Scientifics Announces Successful Product Launch 2
... malnourished in Haiti, which has earned the sobriquet of ... typical signs of malnutrition include swollen bellies, orange hair, ... M.D., associate clinical professor of pediatrics at Washington University ... something about the situation and founded Meds & Food ...
... been awarded a tender to import the H5N2 vaccine for ... Ministry awarded the tender to the company, as the company’s ... among the bidding companies. The company has planned to ... weeks after the receipt of the letter from the government. ...
... to a study published on August 3, 2006, by researchers ... school students// who are physically more active show better academic ... American College of Sports Medicine has published the findings of ... Medicine & Science in Sports & Exercise. ,In ...
... help a 92-year-old woman to commit suicide.// ,Ramesh ... in court to face the charge following investigations into the ... (RCMP). ,Sharma, according to media reports, was helping ... staff member interrupted them. ,Sharma, who appeared in ...
... soft drinks in educational institutions in the state.// ... all educational intuitions in the state from Friday," Rajasthan Education ... applies to 100,000 government and private institutes where over 15 ... continue till it is proved that the contents in the ...
... Zealand have significantly reduced the number of people going for ... said that the poker machine revenue fell 28%. He also ... from pub charities to various sports and other community groups. ... calls received by the gambling helpline also reduced drastically from ...
Cached Medicine News:Health News:Crusade Against Malnutrition 2Health News:Crusade Against Malnutrition 3Health News:Physical Activity Determines Academic Performance 2Health News:Indo-Canadian Doctor Charged with Abetting Suicide Bid 2
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: